Syngene International Limited

How do you expedite your biologics from early stage to large-scale batches—seamlessly?   At Syngene’s Bayview campus in Maryland, scale is built into every step of your biologics manufacturing journey. Whether you're in early development or preparing for commercial launch, we provide a robust end-to-end platform designed for flexibility and speed.    With 50,000 liters of single-use bioreactor capacity and dedicated production lines for monoclonal antibodies (mAbs) and recombinant proteins, the facility strengthens our ability to deliver seamless, end-to-end services—from early-phase development through to commercial manufacturing. Contact us 👉 https://xmrrwallet.com/cmx.plnkd.in/gaWpDEhj   #Syngene #Bayview #BiologicsManufacturing #CDMO #ScalableManufacturing #Biotech #LifeSciences

Presenting an overview of Syngene’s Annual Report 2025 under the theme INNOVATING REACH. At Syngene, Innovating Reach is our way of advancing science with purpose, delivering breakthroughs that matter, and making a meaningful difference to the world.   To read more, visit: https://xmrrwallet.com/cmx.plnkd.in/gv8QGeqY #Syngene #InnovatingReach #CRDMO

Harnessing the Immune System for Cancer Cell Therapy CAR-T therapy is transforming cancer care by reprogramming the body’s immune system to fight cancer. But innovation doesn’t come without its challenges—from high costs and complex manufacturing to safety concerns. In our latest viewpoint, we explore how Syngene is enabling biotech and pharma companies to navigate these challenges and accelerate CAR-T programs from bench to bedside. Read Now 👉 https://xmrrwallet.com/cmx.plnkd.in/gXTsTd_9 #CART #CancerTherapy #CellandGeneTherapy #Oncology #Immunotherapy #Syngene #LifeSciences

We are hiring! We are conducting Walk-in interviews at Bengaluru on 2nd August 2025 (Saturday) for multiple openings in the DMPK (Drug Metabolism & Pharmacokinetics) department.   If you wish to be part of a dynamic, high-performing team for bringing new solutions to drug discovery and changing people's lives for the better, please read more. We seek highly motivated, creative, and results-oriented scientists with positions open at Bangalore and Hyderabad, who have relevant experience in invitro drug metabolism assay, and LCMS-based discovery bioanalysis. The candidate should have an excellent understanding of the fundamentals of drug metabolism and pharmacokinetics principles and drug discovery; prior experience in progressing a project from hit identification to lead optimization is a plus. Qualification and Experience: MSc/MTech/M. Pharm/Ph.D. with 1 to 15 years of relevant experience in ADME or Invitro BA (No Invivo PK openings) (Freshers are not eligible for the current open roles)   Details as below:   Req Id: 60857 - Invitro BA Scientist Click 👉 https://xmrrwallet.com/cmx.plnkd.in/gZVYTk2h   Req Id: 60846 – Invitro ADME Click 👉 https://xmrrwallet.com/cmx.plnkd.in/gvmKcb-q     Job Location: Bangalore and Hyderabad Date & Time for Registration: 2nd Aug 2025, 09:00 AM to 12.30 PM Bengaluru Venue: Syngene International Ltd (The Hub), Tower 8A, 360 Degree Business Park, Doddathoguru, Electronic City, Phase 1, Bengaluru, Karnataka 560100 Location Google Map Link: https://xmrrwallet.com/cmx.plnkd.in/gks345BY     For any queries, please write to 👉 anisha.swain1@syngeneintl.com with the subject line “Syngene DMPK Walk-in Drive” for more details. #WeareHiring #Syngene #WalkinDrive #DMPK

#DidYouKnow Every 30 seconds, a life is lost from hepatitis-related illness. With timely diagnosis, access to treatment, and continued scientific progress, hepatitis is preventable and curable. This World Hepatitis Day, let’s raise awareness, push for faster action, and support efforts to eliminate hepatitis globally. #WorldHepatitisDay #HepCantWait #LiverHealth #PublicHealth #HealthcareInnovation #DrugDiscovery

Reinforcing Science-led Sustainability in Pharma Syngene’s recognition as one of the world’s most sustainable companies of 2025 by TIME and Statista continues to receive global attention. This milestone is now featured in #PharmaTechnologyFocus, spotlighting Syngene’s industry-leading ESG performance and commitment to responsible growth. 🔹 Science-led sustainability in action: 🔹 92% renewable energy 🔹 Zero liquid discharge & 64% recycled water 🔹 95%+ waste diverted from landfills 🔹 SBTi-validated climate targets (1.5°C aligned) 🔹 Green chemistry + My Green Lab certification underway 🔹 #1 in India for women representation in pharma (Fortune India) 🔹 Global expansion: $50M biologics facility in Bayview, U.S. Syngene is paving the way for bringing innovation and impact together! Read now - https://xmrrwallet.com/cmx.plnkd.in/gJ7fdfTq   #Sustainability #GreenPharma #Biotech #Syngene #WomenInSTEM #RenewableEnergy #TIMESmagazine

Revolutionizing Hydrocarbon Analysis with AI.   Syngene recently partnered with a leading organization to overcome the challenges of analyzing hydrocarbon mixtures. Traditional methods like GC-MS and LC-MS fall short when dealing with long-chain hydrocarbons due to the lack of a reference mass spectral library and the complexity of predicting the physical properties of the hydrocarbons.   Our solution? A game-changing AI-based approach! Syngene scientists developed a custom deep learning workflow to:   - Predict mass spectra for long-chain hydrocarbons - Create a comprehensive reference library - Predict probable impurities generated during synthesis from mass spectra data of the sample - Predict key physical properties like viscosity and density   This innovative method enables the identification of compounds in the hydrocarbon mixtures, helping the organization make informed decisions for product formulations. All powered by Syn·AI™, Syngene's AI platform for drug discovery.   Read the full case study here 👉 https://xmrrwallet.com/cmx.plnkd.in/ghUekmQT   #Syngene #AI #Innovation #DataDriven

#GrowwithSyngene: Nurturing Potential, Creating Leaders As part of our commitment to nurturing future-ready leaders, the Accelerated Leadership Program at Syngene offers high-potential talent a unique opportunity to gain broad-based exposure, strategic insight, and hands-on experience across the business. Hear from Dr Ridhima Pandey, one of our dynamic management trainees, as she reflects on her transformative journey through the program and how it has shaped her personal and professional growth. Explore opportunities at Syngene: https://xmrrwallet.com/cmx.plnkd.in/gBZzZ9Td Follow us for more #GrowWithSyngene stories! #Syngene #LifeAtSyngene #Careers

What makes a DMPK program truly successful? It's not just the data—it’s the decisions that data enables.   Vishwottam Kandikere, Head of DMPK at Syngene, reflects on how strategic DMPK thinking supports better outcomes in drug discovery—from understanding compound liabilities to optimizing candidate selection.   Catch Vishwottam Kandikere, Harish Kaushik Kotakonda, PhD and Pattem Rambabu at the second webinar of our #DMPKUnravelled webinar series— 'Overcoming ADMET Challenges in Drug Discovery: Antibiotics and Prodrugs'   🗓️ Date: August 6, 2025 ⏰ Time: 7:30 PM IST | 8 AM EST   Register for the webinar: https://xmrrwallet.com/cmx.plnkd.in/dTDqknt9   #DMPK #DrugDiscovery #Pharmacokinetics #WebinarSeries #SyngeneDiscovery #SyngeneDMPKUnravelled

The Syngene Advantage: Accelerating Progress Through Integrated Technology Transfer   At Syngene, technology transfer is more than a process – it's a seamless, cross-site collaboration designed for efficiency and excellence. This video demonstrates how we connect our R&D and manufacturing capabilities to accelerate your journey from concept to commercialization.   Explore the synergy between our Bangalore (BSEZ) and Mangalore (MSEZ) campuses, driven by robust systems and deep expertise. Our facilities are built for quality, being GMP certified, 21 CFR CFR compliant, and USFDA approved, ensuring global standards are met at every step.   From advanced process and analytical research to meticulous engineering and safety protocols, we emphasize alignment, transparency, and cost-effective execution. Discover how Syngene's commitment to scalable, economical, and safe processes, supported by our dedicated teams, translates into reliable outcomes.   Partner with Syngene for long-term manufacturing and supply solutions, backed by scientific alignment and operational synergy that truly puts science to work. https://xmrrwallet.com/cmx.plnkd.in/gCqrUPJU #Syngene #CDMO #Manufacturing #AnalyticalResearch